Back to Tirzepatide research
tirzepatide gip agonist other 2017-11-15 ClinicalTrials

Tirzepatide's Safety, PK, and PD Evaluated in Japanese Type 2 Diabetes Patients

A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes

Abstract

A Multiple-Ascending Dose Study in Japanese Patients With Type 2 Diabetes Mellitus to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176 NCT ID: NCT03322631 Status: COMPLETED Sponsor: Eli Lilly and Co…

tirzepatide gip agonist glp 1 agonist protocol relevant safety data present
Source: clinicaltrials:NCT03322631 · Ingested 2026-04-03 · Digest: gemini-2.5-flash